GETI.B

194.25

+2.61%↑

CAMX

617.5

+1.98%↑

VITR

143

+1.42%↑

BIOAB

183.4

+3.5%↑

RAY.B

333

-0.6%↓

GETI.B

194.25

+2.61%↑

CAMX

617.5

+1.98%↑

VITR

143

+1.42%↑

BIOAB

183.4

+3.5%↑

RAY.B

333

-0.6%↓

GETI.B

194.25

+2.61%↑

CAMX

617.5

+1.98%↑

VITR

143

+1.42%↑

BIOAB

183.4

+3.5%↑

RAY.B

333

-0.6%↓

GETI.B

194.25

+2.61%↑

CAMX

617.5

+1.98%↑

VITR

143

+1.42%↑

BIOAB

183.4

+3.5%↑

RAY.B

333

-0.6%↓

GETI.B

194.25

+2.61%↑

CAMX

617.5

+1.98%↑

VITR

143

+1.42%↑

BIOAB

183.4

+3.5%↑

RAY.B

333

-0.6%↓

Search

Elekta AB

Cerrado

49.7 1.72

Resumen

Variación precio

24h

Actual

Mínimo

48.64

Máximo

49.88

Métricas clave

By Trading Economics

Ingresos

-817M

-386M

Ventas

461M

5.2B

P/B

Media del Sector

78.936

40.527

BPA

-1.01

Rentabilidad por dividendo

4.91

Margen de beneficios

-7.486

Empleados

4,536

EBITDA

152M

849M

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

4.91%

2.40%

Próximas Ganancias

27 ago 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-443M

19B

Apertura anterior

47.98

Cierre anterior

49.7

Elekta AB Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

2 jul 2025, 17:03 UTC

Principales Movimientos del Mercado

Furniture Companies Rise on U.S. Trade Deal With Vietnam

2 jul 2025, 15:18 UTC

Principales Movimientos del Mercado

Mogo Shares Rally After Embrace of Bitcoin Into Holdings, Operations

2 jul 2025, 23:45 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

2 jul 2025, 23:45 UTC

Charlas de Mercado

Nikkei May Trade Rangebound Amid U.S. Tariff Uncertainty -- Market Talk

2 jul 2025, 23:40 UTC

Charlas de Mercado

Gold Edges Lower Amid Hopes for More Trade Deals -- Market Talk

2 jul 2025, 21:01 UTC

Adquisiciones, fusiones, absorciones

AT&T Completes Sale of Entire Remaining 70% Stake in DIRECTV to TPG >T

2 jul 2025, 21:01 UTC

Adquisiciones, fusiones, absorciones

AT&T and TPG Close DIRECTV Transaction

2 jul 2025, 20:26 UTC

Ganancias

Rivian Stock Drops on Sales Decline. The Stakes Are High for the Rest of 2025. -- Barrons.com

2 jul 2025, 20:22 UTC

Charlas de Mercado

Gold Rises Following Weak ADP Payroll Reading -- Market Talk

2 jul 2025, 20:13 UTC

Charlas de Mercado

Oil Price Expectations Stable in Dallas Fed Survey -- Market Talk

2 jul 2025, 19:09 UTC

Charlas de Mercado

Oil Futures Bounce in Defiance of Downbeat Data -- Market Talk

2 jul 2025, 19:08 UTC

Charlas de Mercado

Dollar Trims Gains as Investors Brace for Cooling Jobs Market -- Market Talk

2 jul 2025, 19:01 UTC

Charlas de Mercado

U.S. Natural Gas Ticks Up Ahead of Storage Data -- Market Talk

2 jul 2025, 18:08 UTC

Charlas de Mercado

Fossil Fuels Rule Energy Roost As U.S. Marks Independence -- Market Talk

2 jul 2025, 17:06 UTC

Adquisiciones, fusiones, absorciones

BCE: Maple Leafs, Raptors Rights Access Through Long-Term Agreement With Rogers, Subject to League Approvals

2 jul 2025, 17:05 UTC

Adquisiciones, fusiones, absorciones

BCE: Access to Content Rights for Toronto Maple Leafs, Toronto Raptors on TSN Secured Through 2043/2044 Season

2 jul 2025, 17:04 UTC

Adquisiciones, fusiones, absorciones

BCE: Proceeds of MLSE Stake Sale to Support Financing of Acquisition of Ziply Fiber

2 jul 2025, 17:04 UTC

Adquisiciones, fusiones, absorciones

BCE Inc. Concludes Sale of Minority Stake in Maple Leaf Sports & Entertainment

2 jul 2025, 17:02 UTC

Adquisiciones, fusiones, absorciones

Rogers Communications: Now Largest Owner With 75% Interest in Maple Leaf Sports & Entertainment

2 jul 2025, 17:02 UTC

Adquisiciones, fusiones, absorciones

Rogers Communications Closes Deal to Buy BCE's 37.5% Stake in Maple Leaf Sports & Entertainment for C$4.7B

2 jul 2025, 16:20 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

2 jul 2025, 16:20 UTC

Charlas de Mercado

Cushing Crude Stock Slide Keeps Bid in WTI -- Market Talk

2 jul 2025, 16:20 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

2 jul 2025, 16:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

2 jul 2025, 16:11 UTC

Charlas de Mercado

Copper Prices Hold Higher on Supply Disruption, Tariff Uncertainty -- Market Talk

2 jul 2025, 16:09 UTC

Charlas de Mercado

Gold Futures Rise, Recouping Some Losses -- Market Talk

2 jul 2025, 15:59 UTC

Ganancias

These Stocks Are Moving the Most Today: Tesla, Centene, Apple, Adobe, Rigetti Computing, Greenbrier, and More -- Barrons.com

2 jul 2025, 15:17 UTC

Charlas de Mercado

Oil Market to Keep Close Watch on U.S. Payrolls -- Market Talk

2 jul 2025, 15:08 UTC

Charlas de Mercado

Luxury Sector Should Report a Slowdown -- Market Talk

2 jul 2025, 15:00 UTC

Adquisiciones, fusiones, absorciones

Glencore: Merger of Viterra With Bunge Global Closed

Comparación entre iguales

Cambio de precio

Elekta AB previsión

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Elekta AB

Elekta AB (publ), a medical technology company, engages in the provision of clinical solutions for treating cancer and brain disorders worldwide. The company offers radiation therapy products, including Elekta Unity for real-time MR visualization; Elekta Versa HD, a brain metastases solution; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; and quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, such as Elekta Esprit; Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Leksell GammaPlan, a treatment planning and management software. In addition, the company offers Elekta ONE, a software suite of multiple Elekta solutions. Further, it provides brachytherapy products, including Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Elekta Xoft Axxent, and electronic brachytherapy systems; Elekta Geneva, an applicator for cervical cancer patients; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Venezia applicator that enables the oncologist to treat locally advanced cervical cancer. Additionally, the company offers neurosurgery products, such as Leksell Vantage Stereotactic System for intracranial neurosurgery. Furthermore, it provides Elekta Kaiku for personalized cancer care; and veterinary radiation therapy solutions. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.